Prevalence of myeloperoxidase gene expression in infant acute lymphocytic leukemia

American Journal of Clinical Pathology

Volumn 110, Issue 5, 1998, Pages 575-581

  Austin, Garth E ^a,b   Alvarado, Carlos S ^b   Austin, Eric D ^a   Hakami, Nasrollah ^c   Zhao, Wei Guo ^a   Chauvenet, Allen ^d   Borowitz, Michael J ^e   Carroll, Andrew J ^f  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Acute lymphocytic leukemia; Gene expression; Myeloperoxidase

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD24 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; RNA;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031784846     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.5.575     Document Type: Article

References (24)

1. Austin GE, Chan WC, Zhao WG, et al. Myeloperoxidase gene expression in normal granulopoiesis and acute leukemias. Leuk Lymphoma. 1994;15:209-226.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-625.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the classification of acute leukemias: French-American-British Cooperative Group. Ann Intern Med. 1976;33:451-458.
4. Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813-819.
5. Ferrari S, Ceccherelli G, Tagliafico E, et al. Detection of low abundance mRNA of myeloid specific genes in cells of acute and chronic lymphoid leukemias by cRNA hybridization. Leukemia. 1990;4:688-693.
6. Urbano-Ispizua A, Matutes E, Villamor N, et al. Clinical significance of myeloid associated antigens in acute lymphoblastic leukemia. Br J Haematol. 1990;75:202-207.
7. Zhou M, Findley HW, Zaki SR, et al. Expression of myeloperoxidase mRNA by leukemic cells from childhood acute lymphoblastic leukemia. Leukemia. 1993;7:1180-1183.
8. Heil G, Gunsisius E, Raghavachar A, et al. Ultrastructural demonstration of peroxidase expression in acute unclassified leukemias: correlation to immunophenotype and treatment outcome. Blood. 1991;77:1305-1312.
9. Kantarjian HM, Hirsch-Ginsberg C, Yee G, et al. Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood. 1990;76:808-813.
10. Koike T, Takahashi M, Shibata A. The therapeutic significance of myeloperoxidase detectable only by electron microscopy in acute leukemia. Leukemia. 1994;8:1253-1255.
11. Frankel LS, Shuster J, Dubowy R, et al. Seeking a better understanding of why infants with leukemia fail to maintain remission. Proc Am Soc Clin Oncol. 1988;52:1459-1462.
12. Pui CH, Behm FG, Downing JR, et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol. 1994;12:909-915.
13. Ludwig WD, Bartam CR, Harbott J, et al. Phenotypic and genotypic heterogeneity in infant acute leukemia, I: acute lymphoblastic leukemia. Leukemia. 1989;3:431-439.
14. Basso G, Putti MC, Cantu-Rajnoldi A, et al. The immunophenotype in infant acute lymphoblastic leukemia: correlation with clinical outcome: an Italian multicentre study (AIEOP). Br J Haematol. 1992;81:184-191.
15. Alvarado CS, Austin GE, Borowitz MJ, et al. Myeloperoxidase gene expression in infant leukemia: a Pediatric Oncology Group study. Leuk Lymphoma. 1998;29:145-160.
16. Hanker JS, Yates PE, Metz CB, et al. A new specific sensitive and non-carcinogenic reagent for the demonstration of horseradish peroxidase. Histochem J. 1977;9:789-793.
17. Zaki SR, Austin GA, Swan D, et al. Human myeloperoxidase gene expression in acute leukemia. Blood. 1989;74:2096-2102.
18. Borowitz MJ, Hunger SP, Carrol AJ, et al. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group Study. Blood. 1993;82:1086-1091.
19. ISCN 1995: An International System for Human Cytogenetic Nomenclature (1995). Recommendations of the international standing committee on Human Cytogenetic Nomenclature, Memphis, Tenn, October 9-13, 1994. Basel, Switzerland: Karger; 1995.
20. Zaki SR, Chan WC, McKolanis J, et al. Production and characterization of monoclonal antibodies to human myeloperoxidase. Clin Immunol Immunopathol. 1989;50:283-297.
21. Morishita Y, Yano K. Myeloperoxidase gene expression in acute leukemias. Nippon Ketsueki Gakkai Zasshi. 1989;1459-1462.
22. Ferrari S, Mariano MT, Tagliafico E, et al. Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. Blood. 1988;72:873-876.
23. + normal human hematopoietic cells. Blood. 1993;82:2069-2078.
24. Berliner N, Hsing A, Graubert T, et al. Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood. 1995;85:799-803.